Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends approval of once-weekly exenatide for type 2 diabetes

April 18, 2011

CHMP adopts positive opinion on Avastin/Xeloda combination in metastatic breast cancer

April 18, 2011

Delcath receives CE mark for Hepatic Chemosat delivery system

April 18, 2011

CHMP recommends new indication for Herceptin in early breast cancer

March 25, 2011

CHMP adopts positive opinion on ViroPharma's Cinryze

March 22, 2011

EMA committee recommends new pediatric indication for Pfizer's Revatio

March 22, 2011

CHMP recommends approval of Eliquis for prevention of venous thromboembolic events

March 22, 2011

CHMP adopts positive opinion regarding new birth control pill NOMAC/E2

March 21, 2011

CHMP adopts negative opinion for Vectibix in combination with chemotherapy

March 21, 2011

CHMP recommends approval of Lucentis in new indication

March 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...